PTGIR
Basic information
Region (hg38): 19:46618550-46625089
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGIR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 5 | 2 |
Variants in PTGIR
This is a list of pathogenic ClinVar variants found in the PTGIR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-46621322-C-T | Benign (Apr 04, 2018) | |||
19-46621334-G-A | not specified | Likely benign (Feb 24, 2025) | ||
19-46621339-C-T | not specified | Uncertain significance (Jan 23, 2025) | ||
19-46621369-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
19-46621392-G-A | not specified | Uncertain significance (May 01, 2024) | ||
19-46621402-C-T | not specified | Uncertain significance (Jun 07, 2022) | ||
19-46621403-G-A | Likely benign (May 04, 2018) | |||
19-46621462-C-T | not specified | Likely benign (Oct 19, 2024) | ||
19-46621485-G-C | Benign (Apr 04, 2018) | |||
19-46621492-C-T | not specified | Uncertain significance (May 27, 2022) | ||
19-46621504-C-T | not specified | Likely benign (Jan 03, 2024) | ||
19-46621524-C-G | not specified | Uncertain significance (May 18, 2023) | ||
19-46621548-G-A | not specified | Uncertain significance (Feb 03, 2025) | ||
19-46621554-C-T | not specified | Uncertain significance (Feb 18, 2025) | ||
19-46621620-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
19-46623480-G-C | not specified | Uncertain significance (Oct 04, 2022) | ||
19-46623543-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
19-46623546-C-T | not specified | Uncertain significance (Apr 12, 2023) | ||
19-46623547-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
19-46623616-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
19-46623688-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
19-46623762-A-G | not specified | Uncertain significance (Aug 20, 2024) | ||
19-46623772-C-A | not specified | Likely benign (Nov 10, 2024) | ||
19-46623772-C-G | not specified | Uncertain significance (May 11, 2022) | ||
19-46623823-A-C | not specified | Uncertain significance (Jul 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTGIR | protein_coding | protein_coding | ENST00000291294 | 2 | 4651 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000888 | 0.582 | 119022 | 0 | 22 | 119044 | 0.0000924 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.390 | 219 | 236 | 0.928 | 0.0000159 | 2355 |
Missense in Polyphen | 66 | 71.71 | 0.92037 | 778 | ||
Synonymous | -0.882 | 131 | 119 | 1.10 | 0.00000949 | 861 |
Loss of Function | 0.466 | 5 | 6.26 | 0.799 | 2.71e-7 | 61 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000296 | 0.0000296 |
Ashkenazi Jewish | 0.000104 | 0.000103 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000207 | 0.000181 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000345 | 0.0000330 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase.;
- Pathway
- Platelet activation - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Celecoxib Pathway, Pharmacodynamics;Platelet Aggregation Inhibitor Pathway, Pharmacodynamics;Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin;Endothelin Pathways;Small Ligand GPCRs;GPCRs, Class A Rhodopsin-like;Prostaglandin Synthesis and Regulation;Signaling by GPCR;Signal Transduction;eicosanoid metabolism;G alpha (s) signalling events;Prostanoid ligand receptors;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Hemostasis;Thromboxane A2 receptor signaling;Prostacyclin signalling through prostacyclin receptor;Platelet homeostasis;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.225
Haploinsufficiency Scores
- pHI
- 0.160
- hipred
- N
- hipred_score
- 0.439
- ghis
- 0.423
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.633
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptgir
- Phenotype
- immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- ptgir
- Affected structure
- heart
- Phenotype tag
- abnormal
- Phenotype quality
- edematous
Gene ontology
- Biological process
- inflammatory response;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;cell-cell signaling;negative regulation of platelet-derived growth factor receptor signaling pathway;response to lipopolysaccharide;negative regulation of smooth muscle cell proliferation
- Cellular component
- cytosol;plasma membrane;integral component of plasma membrane
- Molecular function
- G protein-coupled receptor activity;guanyl-nucleotide exchange factor activity